Jack Phillips - 01 Feb 2023 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role: Chief Executive Officer
Signature: /s/ Steven Reichling, attorney-in-fact
Issuer symbol: AXDX
Transactions as of: 01 Feb 2023
Transactions value $: $0
Form type: 4
Filing time: 01 Feb 2023, 16:38:58 UTC
Previous filing: 17 Jan 2023
Next filing: 15 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXDX	Common Stock	Options Exercise	$0	+10K	+3.99%	$0.00	261K	01 Feb 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXDX	Employee Restricted Stock Units	Options Exercise	$0	-10K	-100%	$0.00^*	0	01 Feb 2023	Common Stock	10K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On February 1, 2020, the reporting person was granted a total of 50,000 restricted stock units, which vests in five equal amounts each year.